High Throughput Telomere Length Assay
June 14 2012 - The Real-Time PCR assay for telomere length is now a service offered by the Dana Farber - Harvard Cancer Center High-throughput Polymorphism Detection Core. Please inquire with the core director, Prof. Immaculata De Vivo.
HSPH Commencement 2012
June 14 2012 - The Immaculata De Vivo laboratory would like to congratulate Dr. Margaret Du and Dr. Jason Liu in earning their Doctor of Science degree in Epidemiology. Margaret successfully defended her thesis on "Physical activity in relation to telomere length and risk of endometrial cancer ". Jason successfully defended his thesis on "The influence of vitamin D and one-carbon metabolism factors on telomere length and endometrial cancer ". Both of these superstars will undoubtly have distinguished research careers ahead of them. Margaret will continue as a post-doctoral fellow at the University of Washington. Jason will continue as a post-doctoral fellow at the National Cancer Institute.
Prof. Immaculata De Vivo and Dr. Margaret Du
HSPH Commencement 2010
June 14 2010 - The Immaculata De Vivo laboratory would like to congratulate Dr. Stalo Karageorgi in earning her Doctor of Science degree in Environmental Health and Epidemiology. After successfully defending her thesis on "Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study", Stalo received her diploma in a lavish commencement ceremony befitting of the most outstanding Harvard graduates.
Prof. Peter Kraft, Prof. Immaculata De Vivo, and the newly minted Dr. Stalo Karageorgi.
Dichloroacetate featured in Cancer Monthly
July 11 2008-Our research on Dichloroacetate is currently featured in this month's edition of Cancer Monthly. The article can be found HERE. A special thank you to Stephanie Watson for the outstanding article.
Telomere Real Time PCR Assay
March 9 2008 - The De Vivo Laboratory is extensively performing assays for the determination of relative telomere length in epidemiological studies. We use a high-throughput 384-well format on an ABI 7900HT platform. We have successfully completed projects for numerous researchers thoughout the country including those at the Harvard School of Public Health and National Cancer Institute.
Manuscripts from several projects and collaborations have been published while numerous others are in preparation. These include:
For more information, please contact Dr. Immaculata De Vivo.
Dichloroacetate: A novel cancer therapeutic agent
March 8 2008 - Our latest manuscript, "Dichloroacetate Induces Apoptosis in Endometrial Cancer Cells" was recently accepted in the journal 'Gynecologic Oncology'. Dichloroacetate is a novel and potentially exciting cancer therapeutic agent which attacks aerobic glycolysis common to most cancers.